Insider Ledger

TAK insider buying and SEC filings, explained

Takeda Pharmaceutical Co. Ltd. · CIK 1395064

Tracked: Forms 3/4/5, 8-K, NT · All filings on sec.gov

Insider activity in the last 12 months

Bought
$0
Insiders who bought
0
Sold (not marked 10b5-1)
$10.6M
Planned sales (10b5-1)
$2.5M

Insider purchases and sales, last 12 months

TradedTypeWhat was filedSource
Sep 14, 2026SaleLauren Rusckowski Duprey (Chief Transformation Officer) sold 34,535 shares at $18.54 ($640K). Holdings down 15% to 191,522 shares. Not marked as a 10b5-1 plan trade.SEC filing
Filed Sep 15, 2026
Sep 2, 2026Planned (10b5-1)Andrew Stewart Plump (President / COO and Director) sold 116,191 shares indirectly (by trust) at $18.49 ($2.1M), marked as a 10b5-1 plan trade. Holdings by trust down 44% to 145,465 shares.SEC filing
Filed Sep 3, 2026
Aug 19, 2026Planned (10b5-1)Andrew Stewart Plump (President / COO and Director) sold 19,651 shares indirectly (by trust) at $18.49 ($363K), marked as a 10b5-1 plan trade. Holdings by trust down 7% to 261,656 shares.SEC filing
Filed Aug 21, 2026
Aug 18, 2026SaleNicola Deidre Petal Greenway (Chief Human Resources Officer) sold 12,980 shares at $18.11 ($235K). Holdings down 24% to 40,049 shares. Not marked as a 10b5-1 plan trade.SEC filing
Filed Aug 19, 2026
Aug 11, 2026SaleElaine Mary Shannon (Pres., Global Supply & Quality) sold 20,363 shares at $17.55 ($357K). Holdings down 23% to 67,311 shares. Not marked as a 10b5-1 plan trade.SEC filing
Filed Aug 12, 2026
Aug 10, 2026SaleAwny Samaan Botros Farajallah (Chief Medical Officer) sold 14,006 shares at about $17.10 ($240K). Holdings down 11% to 116,177 shares. Not marked as a 10b5-1 plan trade.SEC filing
Filed Aug 12, 2026
Aug 10, 2026SaleRamy Riad Ahmed Ibrahim (President / COO) sold 7,277 shares at about $17.10 ($124K). Holdings down 7% to 102,588 shares. Not marked as a 10b5-1 plan trade.SEC filing
Filed Aug 12, 2026
Aug 10, 2026SaleRhonda Janice Pacheco (President / COO) sold 16,901 shares at about $17.10 ($289K). Holdings down 8% to 182,507 shares. Not marked as a 10b5-1 plan trade.SEC filing
Filed Aug 12, 2026
Aug 10, 2026SaleLauren Rusckowski Duprey (Chief Transformation Officer) sold 47,586 shares at about $17.10 ($814K). Holdings down 17% to 226,057 shares. Not marked as a 10b5-1 plan trade.SEC filing
Filed Aug 12, 2026
Aug 10, 2026SaleAndrew Stewart Plump (President / COO and Director) sold 165,393 shares at about $17.10 ($2.8M). Holdings down 18% to 766,569 shares. Not marked as a 10b5-1 plan trade.SEC filing
Filed Aug 12, 2026
Aug 10, 2026SaleAgosti Marcello Pignagnoli (Head, Strat. & Port. Dev) sold 22,957 shares at about $17.10 ($393K). Holdings down 11% to 176,977 shares. Not marked as a 10b5-1 plan trade.SEC filing
Filed Aug 12, 2026
Aug 10, 2026SaleTeresa Marie Bitetti (President / COO) sold 50,012 shares at about $17.10 ($855K). Holdings down 17% to 252,010 shares. Not marked as a 10b5-1 plan trade.SEC filing
Filed Aug 12, 2026
Aug 10, 2026SaleElaine Mary Shannon (Pres., Global Supply & Quality) sold 3,978 shares at about $17.10 ($68K). Holdings down 6% to 63,333 shares. Not marked as a 10b5-1 plan trade.SEC filing
Filed Aug 12, 2026
Aug 10, 2026SaleGabriele Ricci (Chief Data & Tech. Officer) sold 25,088 shares at about $17.10 ($429K). Holdings down 13% to 171,654 shares. Not marked as a 10b5-1 plan trade.SEC filing
Filed Aug 12, 2026
Aug 10, 2026SaleNicola Deidre Petal Greenway (Chief Human Resources Officer) sold 6,774 shares at about $17.10 ($116K). Holdings down 11% to 53,029 shares. Not marked as a 10b5-1 plan trade.SEC filing
Filed Aug 12, 2026
Aug 10, 2026SaleJulie So-Young Kim (CEO and Director) sold 89,090 shares at about $17.10 ($1.5M). Holdings down 19% to 391,489 shares. Not marked as a 10b5-1 plan trade.SEC filing
Filed Aug 12, 2026
Aug 10, 2026SaleGiles Richard Platford (President / COO) sold 31,083 shares at about $17.10 ($532K). Holdings down 9% to 315,838 shares. Not marked as a 10b5-1 plan trade.SEC filing
Filed Aug 12, 2026
Aug 10, 2026SaleNatalie Anne Marie Furney (Global General Counsel) sold 30,868 shares at about $17.10 ($528K). Holdings down 13% to 204,298 shares. Not marked as a 10b5-1 plan trade.SEC filing
Filed Aug 12, 2026
Aug 10, 2026SaleNicola Deidre Petal Greenway (Chief Human Resources Officer) sold 34,603 shares at about $17.51 ($606K). Holdings down 37% to 59,803 shares. Not marked as a 10b5-1 plan trade.SEC filing
Filed Aug 12, 2026

33 routine transactions (such as grants, option exercises or tax withholding) are not listed.

Cluster buys

No cluster buys in the last 12 months.

Red flags

No red flags in the last 12 months.

Key events

No key events in the last 12 months.

8-K filings, last 12 months

No 8-K filings in the last 12 months.

Red flags are objective triggers only: the item or form filed, never an opinion.

Follow TAK in the Insider Ledger app

A plain-English brief of insider purchases, 8-Ks and red flags at the companies you pick. No account needed.

Get the app